Atea Pharmaceuticals, Inc. (AVIR)
3.19
+0.03
(+0.95%)
USD |
NASDAQ |
Dec 11, 15:27
Atea Pharmaceuticals Shareholders Equity (Quarterly): 315.78M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| AbbVie, Inc. | -2.642B |
| KORU Medical Systems, Inc. | 16.46M |
| Erasca, Inc. | 347.89M |
| Coya Therapeutics, Inc. | 27.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 342.96M |
| Total Liabilities (Quarterly) | 27.18M |
| Debt to Equity Ratio | 0.0033 |
| Current Ratio | 16.66 |
| Net Debt Paydown Yield | 0.09% |